Clinical Trial Update: Early Feasibility Study of the MyoRegulator® for Treatment of ALS [NA]

View source ↗

Summary

The early feasibility study of the MyoRegulator for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• MyoRegulator

Snippet

Sponsor: PathMaker Neurosystems Inc. | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: COMPLETED